Genetic association of CCL18 and EGF genes elevate the risk of breast cancer

Author:

Sonia Fatema Akter1,Ferdous Md. Razowanul2,Moududee Sayed Ala3,Bellah Sm Faysal2

Affiliation:

1. Bangabandhu Sheikh Mujibur Rahman Science & Technology University

2. Manarat International University

3. Tulane University

Abstract

Abstract Background: CCL18 and EGF, two biologically plausible cancer biomarkers, are responsible for the emergence and progression of breast invasive carcinoma (BRCA). We aimed to study the expression of the CCL18 and EGF genes and how CCL18 and EGF affect immune function and prognosis in breast cancer.Subjects and methods: To evaluate the relationship between CCL18 and EGF and breast cancer risks, web-based bioinformatics tools were used. The Kaplan-Meier plotter was used to assess the predictive importance of CCL18 and EGF mRNA expression in breast cancer. In order to find whether CCL18 and EGF are independent risk factors for overall survival (OS) and relapse-free survival (RFS) of breast cancer patients, single- and multivariate Cox proportional hazards regression analysis was used. Additionally, STRING database was used to analyze protein-protein interactions.Result: Our findings demonstrated that both CCL18 and EGF exhibit considerable expression and are linked to an elevated risk of breast cancer. In addition, increased expression of CCL18 might indicate poor OS and RFS. Moreover, disease stage and expression level of CCL18 and EGF were correlated with relapse-free survival and overall survival in breast cancer. Analysis of protein-protein interaction based on STRING database gained 8 top genes which could interact with ZWINT, including PMF1, MIS12, DSN1, ZW10, BUB1, BUB1B, CASC5, NDC80, NSL1 and NUF2.Conclusion: Our findings indicate that CCL18 and EGF have high levels of expression in breast tumor tissues and may play a crucial role in the etiology of breast cancer risk.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3